Our pioneering Psychedelic Practitioner Training Program offers a 12-month immersive experience designed for clinicians and professionals committed to the future of mental health care. This comprehensive program bridges clinical expertise with safe, ethical, and effective psychedelic practices, covering modalities like ketamine, MDMA, huachuma, and psilocybin in therapeutic settings.

SoundMind Institute 12-month psychedelic program, highlighted in Forbes, starts this fall. Don’t miss this chance to advance your career!

Thank you to everyone who joined our webinar on psilocybin legalization efforts in New York, New Jersey, and Colorado. We had an incredible discussion led by Dr. Hannah McLane and our esteemed panelists: Allison Hoots, Esq., Tasia Poinsatte, Joshua Kappel, Esq., the Honorable Jeannine LaRue, Joseph Shapiro, Esq., Lisa Gora, Esq., and Sara Price, BSN, RN, NC-BC.

Missed the webinar or want to revisit the insights shared? Watch the webinar here

New York, New Jersey, and Colorado each have psilocybin legalization efforts underway this summer. What is happening in each state? What are the differences? How can you help? What does this mean for the people living in each state?

To discuss these developments further, SoundMind has put together an incredible panel of experts from each state hosted by Dr. Hannah McLane. Our panelists include Allison Hoots, Esq., Tasia Poinsatte, Joshua Kappel, Esq., the Honorable Jeannine LaRue, Joseph Shapiro, Esq., Lisa Gora, Esq., and Sara Price, BSN, RN.

On June 6, 2024, Dr. Hannah McLane testified to the NJ Senate Health Committee to support New Jersey’s ongoing efforts at legalizing psilocybin access. You can read the current version of the bill here on New Jersey’s legislative website.

With Oregon and Colorado paving the way for state-level laws that support legal access to psychedelics, we’re now seeing many other states slowly exploring the possibility of expanding access as well. And on that note, we have exciting news to share!

Recently, our director, Dr. Hannah McLane, had a discussion with Assemblyman Craig J. Coughlin of New Jersey to explore Bill A3852. This bill is known as the "Psilocybin Behavioral Health Access and Services Act,” which aims to authorize the production and use of psilocybin for health and wellness purposes. This is a big deal!

SoundMind Institute is thrilled to extend a heartfelt congratulations to our exceptional team, with a special shoutout to Belinda Eriacho, our esteemed Lead Instructor, curriculum advisor, and Native American Community Liaison, who has been an integral part of our family since 2019! We are immensely proud of Belinda and our dedicated instructors, advisors, and supporters, including Ismail Lourido Ali, Allison Hoots, Rodney Garcia, Joe Tafur, Naomi Tsosie, and many others, whose unwavering commitment has led us to this significant moment.

Join us in supporting the Breakthrough Therapies Act for MDMA and psilocybin mental health treatment!

Dr. Hannah McLane recently accompanied the Veteran Mental Health Leadership Coalition & Reason for Hope in DC for a crucial fly-in focused on the Breakthrough Therapies Act. This bipartisan & bicameral bill aims to streamline R&D for psychedelic-assisted therapy.

With over sixty meetings in just two days, they're making waves in Congress. Together, let's remove barriers and save lives. Check out our blog for more information on Dr. Hannah's Advocacy visit.

Dr. Hannah McLane had the pleasure of speaking with NBC’s Today Show in a segment titled Moms On Mushrooms. During the piece, Hannah explores the effects of psilocybin and its promising ability to treat depression when combined with psychotherapy.

This program is 10 months in length and features monthly groups to learn leadership skills, make connections and network, and create a core group of first cohort BIPOC leaders to conceptualize decolonizing psychedelics from the inside out. We meet monthly with 5 core facilitators. This fellowship is majority BIPOC-only with some additional networking opportunities outside the BIPOC space.

Oregon will approve the first psilocybin therapy facilitators in the country, and the SoundMind Institute is one of a handful of organizations approved to train these new professionals. Founded in 2010 by Dr. Hannah McLane, SoundMind is a grassroots, women-led organization committed to bringing ethics, equity and innovation to psychedelic medicine.

SoundMind’s Psychedelic Facilitator Training Program was recently featured in the MAPS bulletin. We are grateful to have the recognition of Jon Dennis, an esteemed psychedelic advocate and lawyer and are proud to announce that he has joined our advisory team as the Oregon Psilocybin Policy Advisor.

As transgender and gender non-conforming people have long been marginalized within the medical system, it is important to be aware of the unique challenges and needs of this population as we continue to learn how to co-create safe spaces for all people in psychedelic therapy.

Veterans are seeking out cutting edge psychedelic treatments, including ketamine, to address a variety of serious mental health conditions. SoundMind, a psychedelic therapy and training center with a national footprint, has launched our Veteran Peer Support Model to help open doors to these important options.

In this talk, Emma Knighton MA, LMHC, and Hannah McLane MA, MD, MPH, discussed the current literature and research around personality disorders, power dynamics, cults, and boundary violations and how they interact within the psychedelic ecosystem.